Chondrion is a biotechnology company focused on developing therapies for mitochondrial diseases. Leveraging advanced research and technology, Chondrion aims to address the underlying causes of these complex disorders through innovative medicinal solutions. The company is committed to improving the quality of life for individuals affected by mitochondrial dysfunctions, working on cutting-edge approaches in drug development.